Conformational Origin of the Aggregation of Recombinant Human Factor VIII†
✍ Scribed by Grillo, Adeola O.; Edwards, Karen-Leigh T.; Kashi, Ramesh S.; Shipley, Krista M.; Hu, Lina; Besman, Marc J.; Middaugh, C. Russell
- Book ID
- 111885111
- Publisher
- American Chemical Society
- Year
- 2001
- Tongue
- English
- Weight
- 123 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0006-2960
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recombinant human factor VIII (rFVIII), a multidomain glycoprotein is used in replacement therapy for treatment of hemophilia A. Unfortunately, 15%-30% of the treated patients develop inhibitory antibodies. The pathogenesis of antibody development is not completely understood. The presence of aggreg
Heavy metals have been implicated in the aggregation of proteins and the pathophysiology of several neurodegenerative diseases. Herein, we describe the interaction of recombinant human factor VIII (rhFVIII) with Al þ3 , Tb þ3 , Co þ2 , and Fe þ3 using a combination of intrinsic fluorescence, circula